Hepatitis A: Clinical Trials

6 trials for Hepatitis A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Unknown 1
Phase 31Unknown 1

Follow Hepatitis A: new trials by email Literature Review of Hepatitis A trials Research Report on Hepatitis A

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A
honey, molasses - Hepatitis A
Phase 2CompletedAin Shams University502013-11-012014-11-26
Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
SOF, PEG, RBV - Hepatitis C
Phase 2CompletedGilead Sciences472013-02-012014-09-12
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
Varicella Vaccine, Hepatitis A Vaccine - Varicella, Hepatitis A
Phase 2 / Phase 3UnknownUniversity of Sao Paulo General Hospital6002009-06-012009-06-23
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28), Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28) - Japanese Encephalitis, Hepatitis A
Phase 2CompletedSanofi Pasteur, a Sanofi Company3002008-03-012014-10-02
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Pneumococcal (vaccine) - Hepatitis A
Phase 2CompletedGlaxoSmithKline2402006-04-012016-09-28
Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine
Epaxal 0.25 mL, Epaxal 0.5 mL, Havrix Junior 0.5 mL - Hepatitis A
Phase 2CompletedCrucell Holland BV3082004-06-012014-07-29

Narrower conditions

Chickenpox (1)  ·  Digestive System Diseases (1)  ·  Encephalitis, Japanese (1)  ·  Enterovirus Infections (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis C (1)  ·  Hepatitis C, Chronic (1)  ·  Hepatitis, Chronic (1)  ·  Hepatitis, Viral, Human (1)  ·  Liver Diseases (1)  ·  Picornaviridae Infections (1)  ·  RNA Virus Infections (1)  ·  Virus Diseases (1)

Broader conditions

Infections (6)  ·  Digestive System Diseases (5)  ·  Enterovirus Infections (5)  ·  Hepatitis (5)  ·  Hepatitis, Viral, Human (5)  ·  Liver Diseases (5)  ·  Picornaviridae Infections (5)  ·  RNA Virus Infections (5)  ·  Virus Diseases (5)  ·  Arbovirus Infections (1)  ·  Blood-Borne Infections (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)

Interventions

Hepatitis A Vaccines (2)  ·  Chickenpox Vaccine (1)  ·  Honey (1)  ·  Japanese Encephalitis Vaccines (1)  ·  Molasses (1)  ·  Pneumococcal Vaccines (1)  ·  Sofosbuvir (1)  ·  epaxal berna (1)

Sponsors

Ain Shams University (1)  ·  Crucell Holland BV (1)  ·  Gilead Sciences (1)  ·  GlaxoSmithKline (1)  ·  Sanofi Pasteur, a Sanofi Company (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Belgium (1)  ·  Brazil (1)  ·  Chile (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Andre Vertruyen, MD (1)  ·  Glacus S Brito, MD (1)  ·  Mamdouh A Abdulrhman, Professor (1)  ·  Pierre van Damme, MD (1)  ·  Rob Hyland (1)

Results publications

PMID 20856164, PMID 27686833, PMID 27815383